Newhall Charles W III's Form 4 filing
Supernus Pharmaceuticals, Inc. (SUPN) · filed Oct 10, 2025
- Accession no.
- 0001628280-25-044797
- Filed
- Oct 10, 2025
- Trade date
- Oct 9, 2025
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $1.27M. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Newhall Charles W IIICIK 0001005544 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 9, 2025 | Common Stock | SSaleDisposed | −23,800 | $50.73 | −$1,207,374 | 105,844 | Direct | |
| Oct 9, 2025 | Common Stock | SSaleDisposed | −1,200 | $51.55 | −$61,860 | 104,644 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.